JILL Ogden has been appointed to the newly created position of commercial director.
Dr Ogden will be responsible for establishing licensing and commercialisation agreements for the BioSilicon technology platform.
She will examine new commercialisation and licensing opportunities and the development of the group’s existing collaborative partnership portfolio.
Dr Ogden has more than 16 years experience in the commercialisation of biotechnology products and until recently was the UK-based director of business development for Elan Drug Delivery Limited.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.